Table 4 Comparison of high-risk patients undergoing robotic- and open lobectomy
From: Robotic lobectomy has the greatest benefit in patients with marginal pulmonary function
Characteristics | Robotic Lobectomy | Open Lobectomy | p-value |
|---|---|---|---|
(n = 82) | (n = 107) | ||
Age > 75 years | 18 (22%) | 12 (11%) | 0.05 |
Male Gender | 38 (46%) | 55 (51%) | 0.44 |
Zubrod Score | |||
0–1 | 78 (94%) | 100 (93%) | 0.88 |
2+ | 5 (6%) | 7 (7%) | |
Pack years, median (IQR) | 50 (25–67) | 40 (30–66) | 0.035 |
Active smoker | 38 (46%) | 33 (31%) | 0.035 |
COPD | 67 (81%) | 58 (54%) | < 0.001 |
FEV1 [% predicted], mean ± SD | 67.0 ± 17.9 | 62.8 ± 18.0 | 0.10 |
DLCO [% predicted], mean ± SD | 53.6 ± 15.7 | 57.8 ± 16.6 | 0.08 |
BMI > 30 kg/m2 | 20 (24%) | 33 (31%) | 0.47 |
Hypertension | 60 (72%) | 71 (66%) | 0.38 |
Coronary artery disease | 47 (57%) | 52 (49%) | 0.27 |
Peripheral vascular disease | 11 (13%) | 10 (9%) | 0.47 |
Prior cardiothoracic surgery | 13 (16%) | 26 (24%) | 0.15 |
Preop. Chemotherapy | 5 (6%) | 7 (7%) | 0.88 |
Lung Cancer | 69 (83%) | 90 (84%) | 0.86 |
Outcomes | |||
Pulmonary Complication | 23 (28%) | 48 (45%) | 0.015 |
Air Leak (> 5 days) | 4 (5%) | 16 (15%) | 0.024 |
Atelectasis (req. bronchoscopy) | 6 (7%) | 24 (22%) | 0.005 |
Pleural effusion (req. drainage) | 1 (1%) | 5 (5%) | 0.17 |
Pneumonia | 3 (4%) | 12 (11%) | 0.05 |
Respiratory Failure | 10 (12%) | 13 (13%) | |
ARDS | 0 | 3 (3%) | 0.12 |
Pneumothorax | 3 (4%) | 6 (6%) | 0.52 |
Initial vent support > 48 h | 0 | 2 (2%) | 0.21 |
Tracheostomy | 0 | 6 (6%) | 0.028 |
Other pulmonary event | 3 (4%) | 1 (1%) | 0.32 |
Length of hospitalization [days] Median (IQR) | 4 (4–7) | 8 (5–12) | < 0.001 |
Major Complications | 16 (19%) | 26 (24%) | 0.41 |
Mortality | 1 (1%) | 2 (2%) | 0.73 |